| 01/14 | ABIOMED : Third Quarter Fiscal 2021 Earnings and Conference Call Notification | BU |
| 01/07 | ABIOMED : Continues to Strengthen its Intellectual Property, Now Holds More Than.. | BU |
| 2020 | ABIOMED : to Present at the 39th Annual J.P. Morgan Healthcare Conference | BU |
| 2020 | ABIOMED : First Patients, Including a COVID-19 Patient, Treated with Abiomed's I.. | AQ |
| 2020 | ABIOMED : First Patients, Including a COVID-19 Patient, Treated with Abiomed's I.. | BU |
| 2020 | ABIOMED : Two Milestones Achieved Toward Small Bore Access with Impella | AQ |
| 2020 | ABIOMED : Two Milestones Achieved Toward Small Bore Access with Impella | BU |
| 2020 | ABIOMED : to Hold Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthc.. | AQ |
| 2020 | ABIOMED : to Hold Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthc.. | BU |
| 2020 | ABIOMED : to Hold Fireside Chat at the Stephens Annual Investment Conference 202.. | BU |
| 2020 | ABIOMED INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE.. | AQ |
| 2020 | ABIOMED : First 1,000 Patients Treated with Impella 5.5 with SmartAssist, a Hear.. | AQ |
| 2020 | ABIOMED : First 1,000 Patients Treated with Impella 5.5 with SmartAssist, a Hear.. | BU |
| 2020 | ABIOMED : Announces Q2 FY 2021 Revenue of $210 Million, Up 27% over Q1 FY 2021 a.. | AQ |
| 2020 | ABIOMED : First Patients Treated with the World's Smallest Heart Pump, the 9Fr I.. | AQ |
| 2020 | ABIOMED INC : Results of Operations and Financial Condition, Financial Statement.. | AQ |
| 2020 | ABIOMED : Fiscal 2Q Earnings Snapshot | AQ |
| 2020 | ABIOMED : Announces Q2 FY 2021 Revenue of $210 Million, Up 27% Over Q1 FY 2021 a.. | BU |
| 2020 | ABIOMED : First Patients Treated with the World's Smallest Heart Pump, the 9Fr I.. | BU |
| 2020 | ABIOMED : FDA Grants 510(k) Clearance for Abiomed's Innovative Cardiopulmonary S.. | AQ |
| 2020 | ABIOMED : FDA Grants 510(k) Clearance for Abiomed's Innovative Cardiopulmonary S.. | BU |
| 2020 | ABIOMED : Data Presented at TCT Connect Finds Pre-PCI Use of Impella for AMI Car.. | AQ |
| 2020 | ABIOMED : Largest Study of Hemodynamically Supported High-Risk PCI Patients Find.. | AQ |
| 2020 | ABIOMED : to Host a Virtual Meeting to Discuss New Clinical Data Presented at TC.. | AQ |
| 2020 | ABIOMED : Studies Presented at TCT Connect Associate Higher Survival With Early .. | BU |
| 2020 | ABIOMED : Data Presented at TCT Connect Finds Pre-PCI Use of Impella for AMI Car.. | BU |
| 2020 | ABIOMED : to Host a Virtual Meeting to Discuss New Clinical Data Presented at TC.. | BU |
| 2020 | ABIOMED : Largest Study of Hemodynamically Supported High-Risk PCI Patients Find.. | BU |
| 2020 | ABIOMED : Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves.. | BU |
| 2020 | ABIOMED : Second Quarter Fiscal 2021 Earnings and Conference Call Notification | AQ |
| 2020 | ABIOMED : TCT Connect to Highlight How Impella Enables Improved Outcomes for Hig.. | AQ |
| 2020 | ABIOMED : Second Quarter Fiscal 2021 Earnings and Conference Call Notification | BU |
| 2020 | ABIOMED : TCT Connect to Highlight How Impella Enables Improved Outcomes for Hig.. | BU |
| 2020 | ABIOMED : to Hold Fireside Chat at the Raymond James North American Equities Con.. | AQ |
| 2020 | ABIOMED : to Hold Fireside Chat at the Raymond James North American Equities Con.. | BU |
| 2020 | ABIOMED : to Hold Fireside Chat at the 18th Annual Morgan Stanley Global Healthc.. | AQ |
| 2020 | ABIOMED : to Hold Fireside Chat at the 18th Annual Morgan Stanley Global Healthc.. | BU |
| 2020 | ABIOMED INC : Other Events (form 8-K) | AQ |
| 2020 | ABIOMED INC : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
| 2020 | ABIOMED INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE.. | AQ |
| 2020 | ABIOMED INC : Results of Operations and Financial Condition, Financial Statement.. | AQ |
| 2020 | ABIOMED : Fiscal 1Q Earnings Snapshot | AQ |
| 2020 | ABIOMED : Announces Q1 FY 2021 Revenue of $165 Million and 21% Operating Margin | BU |
| 2020 | ABIOMED : FDA grants emergency use for heart pump in COVID-19 cases | AQ |
| 2020 | ABIOMED : FDA Issues Emergency Use Authorization for Impella Heart Pumps to Prov.. | BU |
| 2020 | ABIOMED : Large Multi-Center Study in Japan Finds High Survival Rates with Use o.. | AQ |
| 2020 | ABIOMED : Large Multi-Center Study in Japan Finds High Survival Rates with Use o.. | BU |
| 2020 | ABIOMED : First Quarter Fiscal 2021 Earnings and Conference Call Notification | BU |
| 2020 | ABIOMED : FDA Approves Data Streaming from the Impella Console, Setting the Stag.. | BU |
| 2020 | ABIOMED : Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Oth.. | AQ |
| 2020 | ABIOMED : Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Oth.. | BU |
| 2020 | ABIOMED : Appoints New Chief Medical Officer Charles Simonton, M.D | AQ |
| 2020 | ABIOMED : Launches Virtual Physician Education Program, CAMP PCI, to Improve Hig.. | BU |
| 2020 | ABIOMED : Appoints New Chief Medical Officer Charles Simonton, M.D. | BU |
| 2020 | ABIOMED : FDA Approves Abiomed's First-in-Human Trial of Impella ECP, World's Sm.. | AQ |
| 2020 | ABIOMED : FDA Approves Abiomed's First-in-Human Trial of Impella ECP, World's Sm.. | BU |
| 2020 | ABIOMED : to Hold Fireside Chat at the William Blair 40th Annual Growth Stock Co.. | BU |
| 2020 | ABIOMED : FDA Issues Emergency Use Authorization for Impella RP as Therapy for C.. | AQ |
| 2020 | ABIOMED : FDA Issues Emergency Use Authorization for Impella RP as Therapy for C.. | BU |
| 2020 | ABIOMED : to Hold Fireside Chat at Jefferies Virtual Healthcare Conference | BU |
| 2020 | ABIOMED : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT.. | AQ |
| 2020 | ABIOMED : to Host Virtual Clinical Data and Innovation Day | BU |
| 2020 | ABIOMED : PROTECT III Study Shows Placing Impella Prior to High-Risk PCI is Asso.. | BU |
| 2020 | ABIOMED INC : Other Events (form 8-K) | AQ |
| 2020 | ABIOMED INC : Results of Operations and Financial Condition, Change in Directors.. | AQ |
| 2020 | ABIOMED : Fiscal 4Q Earnings Snapshot | AQ |
| 2020 | ABIOMED : Announces Q4 FY 2020 Revenue of $207 Million and 28.1% Operating Margi.. | BU |
| 2020 | ABIOMED : Expands Product Portfolio with Acquisition of Cardiopulmonary Support .. | AQ |
| 2020 | ABIOMED : Expands Product Portfolio with Acquisition of Cardiopulmonary Support .. | BU |
| 2020 | ABIOMED : Fourth Quarter Fiscal 2020 Earnings and Conference Call Notification | AQ |
| 2020 | ABIOMED : Fourth Quarter Fiscal 2020 Earnings and Conference Call Notification | BU |
| 2020 | ABIOMED : Response to the COVID-19 Pandemic | AQ |
| 2020 | ABIOMED : 's Response to the COVID-19 Pandemic | BU |
| 2020 | ABIOMED : Study of 21,848 High-Risk PCI Patients Demonstrates Lower Risk of Deat.. | BU |
| 2020 | ABIOMED INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE.. | AQ |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
